Response to EPOCH chemotherapy
| Category . | Total no. . | CR, no. (%; 95% CI) . | PR, no. (%) . | RR, no. (%) . |
|---|---|---|---|---|
| All patients3-150 | 49 | 45 (92; 80-98) | 4 (8) | 49 (100) |
| IPI score | ||||
| Low risk (0-2) | 27 | 26 (96; 81-100) | 1 (4) | 27 (100) |
| High risk (3-5) | 22 | 19 (86; 65-97) | 3 (14) | 22 (100) |
| Category . | Total no. . | CR, no. (%; 95% CI) . | PR, no. (%) . | RR, no. (%) . |
|---|---|---|---|---|
| All patients3-150 | 49 | 45 (92; 80-98) | 4 (8) | 49 (100) |
| IPI score | ||||
| Low risk (0-2) | 27 | 26 (96; 81-100) | 1 (4) | 27 (100) |
| High risk (3-5) | 22 | 19 (86; 65-97) | 3 (14) | 22 (100) |
CR indicates complete response; CI, confidence interval; PR, partial response; RR, overall response rate; and IPI, International Prognostic Index.
One patient had no measurable disease after tumor resection.